Blockchain-Based Pilot for Exchange of Clinical Data Announced by Grapevine World in Collaboration With the University of Southampton and Tiani Spirit

Food and Healthcare Press Releases Tuesday July 31, 2018 14:30
VIENNA--31 Jul--PRNewswire/InfoQuest

Grapevine World is a decentralized ecosystem for the seamless exchange and utilization of health data in a standardized, secure manner. In collaboration with the University of Southampton and Tiani Spirit, a new blockchain-enabled platform using the trusted Microsoft Azure cloud platform to track the provenance of healthcare data has been developed to break down data barriers and simplify the access and the ability to utilize health data for professionals.

The importance of medical data, its origins and quality have long been recognized in clinical research. Data provenance is the foundation of data quality, commonly implemented by automatically capturing the trace of data manipulation over space and time.

This pilot aims to demonstrate the value of combining market-proven interoperability standards in health data exchange (IHE) and blockchain technology (Hyperledger Fabric) for tracking and assessing health data provenance. The pilot will act as a trial run to assess the potential of the solution for clinical trial matching for one of Grapevine's early adopters, a Forbes 100 pharmaceutical corporation (requesting to remain unnamed at the time of the announcement).

"Following a successful pilot execution with our early adopter, we are excited to receive strong interest from multiple health and life science organisations to subsequently adopt our solution. Benefiting from Microsoft's global reach and strong support from the interoperability community, we meet a growing market need and will together overcome the current limitations for achieving a truly connected healthcare community," highlights Wernhard Berger, Chief Business Development Officer and Co-Founder of Grapevine World.

The "clinical trial matching" use case serves only as an initial launching pad for Grapevine's platform, which is designed to facilitate the consented data access for various types of organisations with a need for large-scale health data (universities, med- and biotech companies, etc.).

Powered by Azure, Grapevine can more easily overcome privacy, security, performance, and scalability challenges preventing many blockchain-based projects from reaching production stage, and limiting real-world adoption of the emergent technology in healthcare.

"Blockchain holds great potential for healthcare consortiums to collaborate to improve the quality of care, lower costs, and improve the experience of patients and healthcare workers. Powered by Microsoft Azure, Grapevine can overcome many of the challenges preventing many blockchain-based projects from reaching production stage, and limiting real-world adoption of this emergent technology in healthcare. Azure delivers industry-leading cloud-based security and compliance capabilities to empower healthcare consortiums to leverage blockchain to its full potential to help improve healthcare." David Houlding CISSP CIPP, Principal Healthcare Lead, Microsoft Azure.

Find more information about how this joint solution can benefit your organisation at   http://www.grapevineworldtoken.io/clinical-trial-pilot .
Contact: Kate Alippa,   kate@7marketzgroup.com   , +357-96545696
Source: Grapevine World

Latest Press Release

Venus Medtech Launches Global Advisory Board to Target for International Market

Venus Medtech (Hangzhou) Inc., a Chinese medical device company specializing in transcatheter valve replacement therapy, has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board. The Board...

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report " Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality...

PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group...

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular...

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

Related Topics